RBC Capital analyst Ben Hendrix reiterated a Buy rating on Pennant Group (PNTG – Research Report) yesterday and set a price target of $26.00. The company’s shares closed yesterday at $22.14.
According to TipRanks, Hendrix is a 4-star analyst with an average return of 4.5% and a 55.61% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Brookdale Senior Living, and Community Health.
In addition to RBC Capital, Pennant Group also received a Buy from Oppenheimer’s Michael Wiederhorn in a report issued on May 7. However, on the same day, Truist Financial maintained a Hold rating on Pennant Group (NASDAQ: PNTG).
PNTG market cap is currently $665.2M and has a P/E ratio of 40.77.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PNTG in relation to earlier this year. Most recently, in March 2024, John J Gochnour, the COO of PNTG bought 10,700.00 shares for a total of $56,817.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pennant Group (PNTG) Company Description:
The Pennant Group, Inc. engages in the provision of healthcare services. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes mobile diagnostic and laboratory services. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.
